Alibaba Group (BABA 1.90%) has spent the past few years navigating regulatory pressure, intense competition, and shifting investor sentiment. But as the company enters 2026, the picture is becoming clearer. The business is stabilizing in some areas while accelerating rapidly in others. Based on recent earnings and industry trends, two developments are likely to define Alibaba's story in 2026. 1. E...
Alibaba Group (BABA 1.90%) has spent the past few years navigating regulatory pressure, intense competition, and shifting investor sentiment. But as the company enters 2026, the picture is becoming clearer. The business is stabilizing in some areas while accelerating rapidly in others. Based on recent earnings and industry trends, two developments are likely to define Alibaba's story in 2026. 1. E-commerce growth will remain modest, and margins may stay under pressure Alibaba's core e-commerce platforms, Taobao and Tmall, are no longer the hypergrowth engines they once were. But they remain the company's foundation, generating the bulk of revenue and user engagement. Recent results suggest the segment is stabilizing. In the quarter ending in December 31, 2025, Alibaba reported China commerce revenue growth of 6% year over year, driven mainly by the rapid expansion of quick commerce. While the recent performance has improved compared to the last two years, investors should note that competition across China's e-commerce landscape remains fierce. Platforms such as Pinduoduo and Douyin continue to challenge traditional marketplaces with low-price strategies and short-video commerce experiences. To defend its ecosystem, Alibaba has been investing heavily in improving customer mindshare through a stronger value proposition, enhanced services, and instant commerce. These initiatives help maintain user engagement but come at a cost. The company's earnings have come under pressure due to higher spending on quick commerce, user experience and technology. Given these dynamics, a realistic scenario for 2026 is mid-to-high-single-digit growth in the e-commerce segment and continued margin pressure as Alibaba balances market share with profitability. Expand NYSE : BABA Alibaba Group Today's Change ( -1.90 %) $ -2.37 Current Price $ 122.53 Key Data Points Market Cap $275B Day's Range $ 122.09 - $ 126.30 52wk Range $ 94.97 - $ 192.67 Volume 690K Avg Vol 12M Gross Margin 40.43 % Di...
Key Points Alibaba's e-commerce business is stabilizing but unlikely to return to hypergrowth. AI demand is rapidly accelerating Alibaba's cloud business. While commerce remains foundational, cloud and AI could become the company's primary long-term growth engine. 10 stocks we like better than Alibaba Group › Alibaba Group (NYSE: BABA) has spent the past few years navigating regulatory pressure, i...
Key Points Alibaba's e-commerce business is stabilizing but unlikely to return to hypergrowth. AI demand is rapidly accelerating Alibaba's cloud business. While commerce remains foundational, cloud and AI could become the company's primary long-term growth engine. 10 stocks we like better than Alibaba Group › Alibaba Group (NYSE: BABA) has spent the past few years navigating regulatory pressure, intense competition, and shifting investor sentiment. But as the company enters 2026, the picture is becoming clearer. The business is stabilizing in some areas while accelerating rapidly in others. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Based on recent earnings and industry trends, two developments are likely to define Alibaba's story in 2026. 1. E-commerce growth will remain modest, and margins may stay under pressure Alibaba's core e-commerce platforms, Taobao and Tmall, are no longer the hypergrowth engines they once were. But they remain the company's foundation, generating the bulk of revenue and user engagement. Recent results suggest the segment is stabilizing. In the quarter ending in December 31, 2025, Alibaba reported China commerce revenue growth of 6% year over year, driven mainly by the rapid expansion of quick commerce. While the recent performance has improved compared to the last two years, investors should note that competition across China's e-commerce landscape remains fierce. Platforms such as Pinduoduo and Douyin continue to challenge traditional marketplaces with low-price strategies and short-video commerce experiences. To defend its ecosystem, Alibaba has been investing heavily in improving customer mindshare through a stronger value proposition, enhanced services, and instant commerce. These initiatives help maintain user engagement but come at a cost. The company's earni...
Iran's First Use Of ICBMs Raises Serious Questions About Remaining Arsenal In a startling move that has military experts questioning their assumptions about Iranian capabilities, Iran attempted to hit the joint UK-US base on the Indian Ocean island of Diego Garcia with two intermediate-range ballistic missiles (IRBMs). While US officials assured the Wall Street Journal that the base was unscathed,...
Iran's First Use Of ICBMs Raises Serious Questions About Remaining Arsenal In a startling move that has military experts questioning their assumptions about Iranian capabilities, Iran attempted to hit the joint UK-US base on the Indian Ocean island of Diego Garcia with two intermediate-range ballistic missiles (IRBMs). While US officials assured the Wall Street Journal that the base was unscathed, the Iranian strike aimed at a target roughly 4,000 kilometers from Iran suggests that the range of Iran's retaliatory capacity could be well beyond previous external estimates and claims made by Iran. According to two officials who gave the Journal a Friday-night scoop on the story, one missile had a mid-flight malfunction, while the other was engaged by an SM-3 interceptor missile fired from a US Navy vessel. It's not clear, however, if that interceptor actually hit its target. Nor does the report indicate when the strike was attempted. While it's home to a joint base, Diego Garcia is a British Overseas Territory. After the bombs started falling on Iran on Feb. 28, British Prime Minister Keir Starmer initially refused to allow the United States to use Diego Garcia and other UK bases in the campaign against Iran. He soon folded, announcing that the bases could be used for so-called "defensive" operations focused on hitting Iranian missile launchers targeting UK interests. On Friday, the permission was expanded to include supporting strikes on Iranian assets targeting the Strait of Hormuz. Also on Friday, Iran warned that the accommodation of US military maneuvering makes the UK a "participant in aggression," adding that Iran "reserve[s] our inherent right to defend the country's sovereignty and independence." Last month -- three days before US-Israeli surprise attack -- Iranian Foreign Minister Abbas Araghchi claimed that Iran had, of its own volition, "deliberately limited" the range of its ballistic missiles to 2,000 kilometers, or 1,243 miles. On the same day, Secretary...
Movsar Evloev put a huge dent in Lerone Murphy's featherweight title dream as the Russian secured a majority decision victory at UFC London. In a fight seen by many as a number one contender contest at the O2 Arena, Evloev ground his British opponent down as the fight wore on to win, with two judges scoring it 48-46 in the Russian's favour and one deeming it a draw at 47-47. Manchester's Murphy ha...
Movsar Evloev put a huge dent in Lerone Murphy's featherweight title dream as the Russian secured a majority decision victory at UFC London. In a fight seen by many as a number one contender contest at the O2 Arena, Evloev ground his British opponent down as the fight wore on to win, with two judges scoring it 48-46 in the Russian's favour and one deeming it a draw at 47-47. Manchester's Murphy had many good moments in a competitive contest but an injury to the 34-year-old's hip in the third round left Evloev finishing the fight stronger. The defeat ends Murphy's 18-fight unbeaten streak, while Evloev, 32, extends his undefeated record to 20 fights and puts himself in prime position to face champion Alexander Volkanovski. Murphy is ranked third in UFC's featherweight rankings and is likely to need a landmark win over a high-ranked opponent to put himself back in the title picture. "Sorry for not giving you a fight. Make sure Evloev gets a title shot. He deserves it," said Murphy, who remained positive despite defeat. "Yes, my hip popped in the third round, but no excuses. I'll be back. I've got work to do, but i'll be back." Despite some impressive wins from British fighters like Nathaniel Wood and Mason Jones, the atmosphere lacked the buzz of previous UFC shows in London. On a card lacking stars from previous years like Tom Aspinall and Paddy Pimblett, Murphy was given a golden opportunity to bask in the spotlight but Evloev had other ideas.
Jesse Gary, President and CEO of Century Aluminum Company (CENX 1.41%), reported the sale of 150,000 shares for a transaction value of ~$8.32 million on March 16, 2026, according to a SEC Form 4 filing. Transaction summary Metric Value Shares sold (indirect) 150,000 Transaction value $8.3 million Post-transaction shares (direct) 277,227 Post-transaction shares (indirect) 142,580 Post-transaction v...
Jesse Gary, President and CEO of Century Aluminum Company (CENX 1.41%), reported the sale of 150,000 shares for a transaction value of ~$8.32 million on March 16, 2026, according to a SEC Form 4 filing. Transaction summary Metric Value Shares sold (indirect) 150,000 Transaction value $8.3 million Post-transaction shares (direct) 277,227 Post-transaction shares (indirect) 142,580 Post-transaction value (direct ownership) $15.4 million Transaction value based on SEC Form 4 reported price ($55.47); post-transaction value calculated using available share and transaction data. Key questions How does this sale compare to the executive’s historical selling activity? This transaction matches the largest recorded individual sale by share count over the past three years and exceeds the historical median sell transaction of 79,243 shares, based on three sell trades since July 2023. This transaction matches the largest recorded individual sale by share count over the past three years and exceeds the historical median sell transaction of 79,243 shares, based on three sell trades since July 2023. What are the mechanics and implications of the indirect sale? All shares sold were held in a revocable trust controlled by Gary, and the transaction was executed under a Rule 10b5-1 plan that has now been completed, signaling pre-arranged liquidity rather than discretionary selling. Expand NASDAQ : CENX Century Aluminum Today's Change ( -1.41 %) $ -0.70 Current Price $ 48.95 Key Data Points Market Cap $4.8B Day's Range $ 48.20 - $ 51.37 52wk Range $ 13.05 - $ 59.12 Volume 111K Avg Vol 2.4M Gross Margin 10.44 % Company overview Metric Value Price $48.97 Market capitalization $4.85 billion Revenue (TTM) $2.53 billion 1-year price change 148.20% *Price and 1-year performance calculated using March 16th, 2026 as the reference date. Company snapshot Century Aluminum Company is a leading producer of various metals, including standard-grade and value-added primary aluminum products. It operates...
Key Points DAFNA Capital Management sold 222,847 SNDX shares in the fourth quarter for an estimated roughly $4 million. Meanwhile, the quarter-end position value decreased by $1.87 million, reflecting both trading and price movements. The position now represents roughly 1.4% of reportable AUM, outside the fund’s top five holdings. 10 stocks we like better than Syndax Pharmaceuticals › DAFNA Capita...
Key Points DAFNA Capital Management sold 222,847 SNDX shares in the fourth quarter for an estimated roughly $4 million. Meanwhile, the quarter-end position value decreased by $1.87 million, reflecting both trading and price movements. The position now represents roughly 1.4% of reportable AUM, outside the fund’s top five holdings. 10 stocks we like better than Syndax Pharmaceuticals › DAFNA Capital Management reported selling 222,847 shares of Syndax Pharmaceuticals (NASDAQ:SNDX) in its February 17, 2026, SEC filing, with the estimated transaction value at $3.89 million based on quarterly average pricing. What happened According to an SEC filing dated February 17, 2026, DAFNA Capital Management reduced its position in Syndax Pharmaceuticals by 222,847 shares during the fourth quarter. The estimated value of the shares sold was approximately $3.89 million, based on the mean unadjusted closing price for the quarter. The value of the stake at quarter’s end declined by $1.87 million, reflecting both share sales and price movement. What else to know The fund’s position in Syndax Pharmaceuticals now accounts for 1.36% of its $430.52 million 13F reportable assets, down from 1.90% in the prior quarter. Top holdings after the filing: NASDAQ: RVMD: $48.15 million (11.3% of AUM) NYSEMKT: XBI: $41.03 million (9.7% of AUM) NYSEMKT: STXS: $31.47 million (7.4% of AUM) NASDAQ: ATRC: $23.63 million (5.6% of AUM) NASDAQ: CYTK: $23.57 million (5.5% of AUM) As of Friday, Syndax Pharmaceuticals shares were priced at $24.23, up 72% over the past year and well outperforming the S&P 500, which is instead up about 15% in the same period Company overview Metric Value Price (as of Friday) $24.23 Market Capitalization $2.1 billion Revenue (TTM) $172.4 million Net Income (TTM) ($285.4 million) Company snapshot Syndax Pharmaceuticals develops oncology therapies, including SNDX-5613 for acute myeloid leukemia and axatilimab for chronic graft versus host disease; the pipeline also includes Entinos...
Key Points AI stocks have underperformed the market in 2026. Many AI stocks are still growing at a rapid pace. 10 stocks we like better than Nvidia › You may be surprised to learn that even with a war in Iran and a so-so economy, the S&P 500 is only down around 5% from its high. The reality is that there's a lot of strength in various sectors across the market, and most companies are doing just fi...
Key Points AI stocks have underperformed the market in 2026. Many AI stocks are still growing at a rapid pace. 10 stocks we like better than Nvidia › You may be surprised to learn that even with a war in Iran and a so-so economy, the S&P 500 is only down around 5% from its high. The reality is that there's a lot of strength in various sectors across the market, and most companies are doing just fine. However, there's one sector of the market that isn't doing as well as the others in 2026, and it may come as a surprise: artificial intelligence (AI). Although AI gets a ton of publicity and a huge amount of spending, investors haven't shown these stocks nearly as much love as they did during the previous three years. This has caused many impressive AI stocks to sell off, which may be a huge warning sign about the sector as a whole. However, I think investors should get a different signal from this sell-off, and now is the time to act. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » AI stocks look like bargains While there isn't an AI index investors can point to, one common exchange-traded fund (ETF) I use to track general AI stock performance is the Global X Artificial Intelligence & Technology ETF. This ETF is down around 9% from its all-time high, so it has fallen considerably more than the S&P 500, but it's still not a level most would find concerning. If you peel back the layers a bit and look at some top investment options, you'll see several popular AI stocks down significantly from their highs. Among them are Nvidia (NASDAQ: NVDA), Microsoft (NASDAQ: MSFT), and Palantir Technologies (NASDAQ: PLTR). These three represent the leaders in three different areas of AI investing. Nvidia is a play on AI infrastructure, Palantir is an AI software company, and Microsoft is a cloud infrastructure and bu...
Naomi Osaka has said she does not intend to continue competing if she frequently loses in first round matches after suffering a disappointing 7-5, 6-4 defeat to Australia’s Talia Gibson in her opening match of the Miami Open. Osaka, who received a first-round bye as the 16th seed in Miami, moved sluggishly in an error-strewn performance and was outplayed by the talented 21-year-old Gibson, who wil...
Naomi Osaka has said she does not intend to continue competing if she frequently loses in first round matches after suffering a disappointing 7-5, 6-4 defeat to Australia’s Talia Gibson in her opening match of the Miami Open. Osaka, who received a first-round bye as the 16th seed in Miami, moved sluggishly in an error-strewn performance and was outplayed by the talented 21-year-old Gibson, who will play Iva Jovic in the next round. A question on Osaka’s plans for the upcoming clay court season prompted the 28-year-old to reflect on the difficulties of juggling motherhood with her goals as a professional tennis player. Osaka, who said she would play an abbreviated clay season starting at the Madrid Open, does not believe she can be the best mother possible while pursuing those goals. “I feel like this also is a dilemma for me,” Osaka told a small group of reporters. “Obviously, I would love to play, but like I said last year … for me, my daughter is very important, and I want to be a mom. I want to be the best mom I can, but sometimes I feel like I know what I have to do to become a really good player, and it’s very difficult. I’m not going to play Charleston. I hope I can play Madrid, Rome and then obviously the French Open. Things have been challenging for Osaka since returning to competition in 2024 soon after giving birth to her daughter, Shai. She seemed to take a significant step forward at the end of last year, reaching the US Open semi-finals and the final of the Canada Open in Montreal. Osaka’s progress has also been hampered by injuries. She was forced to withdraw from the Australian Open after a relapse of her chronic abdominal injury, which she says is connected to her pregnancy. Osaka said she has been struggling with a back injury over the past week, which she joked was due to old age. “Your girl’s getting old out here,” she said, laughing. “For me, like I said last year, I’m not going to stay on tour if I’m losing in the first round,” Osaka added. “I’d...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Palantir Technologies (NasdaqGS:PLTR) has had its Maven AI technology designated as a "program of record" by the U.S. Department of Defense. The designation formalizes Maven AI’s adoption across all U.S. military branches and secures stable, long term funding. This move positions...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Palantir Technologies (NasdaqGS:PLTR) has had its Maven AI technology designated as a "program of record" by the U.S. Department of Defense. The designation formalizes Maven AI’s adoption across all U.S. military branches and secures stable, long term funding. This move positions Maven AI as a core component in U.S. military operations, replacing ad hoc or pilot style contracts. Palantir, known for its data analytics and AI software for government and commercial clients, now has Maven AI embedded more formally within U.S. defense planning and budgeting. For readers tracking defense related software providers, this designation stands out because it ties Palantir’s technology directly into the U.S. military’s standard programs rather than short term projects. For investors watching NasdaqGS:PLTR, the new status for Maven AI may influence how they think about the durability of Palantir’s government revenue and the depth of its relationship with the Department of Defense. It also gives context for comparing Palantir’s role against other defense and AI software suppliers that may still be working largely on pilots or one off contracts. Stay updated on the most important news stories for Palantir Technologies by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Palantir Technologies. NasdaqGS:PLTR Earnings & Revenue Growth as at Mar 2026 📰 Beyond the headline: 0 risks and 2 things going right for Palantir Technologies that every investor should see. Quick Assessment ⚖️ Price vs Analyst Target : At US$150.68 versus a US$186.60 consensus target, the price is roughly 19% below where analysts, on average, expect it to be. ❌ Simply Wall St Valuation : Shares are trading about 23.5% above Simply Wall St's estimated fair value, which flags valuation as stretched. ✅ Recent Momentum: A 30 day return of ...
李強：十五五規劃綱要為中國新藍圖、世界新機遇 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】為期兩天的中國發展高層論壇在北京開幕，總理李強稱「十五五」規劃綱要是中國發展的新藍圖及世界發展的新機遇。 李強：「中國的...
李強：十五五規劃綱要為中國新藍圖、世界新機遇 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】為期兩天的中國發展高層論壇在北京開幕，總理李強稱「十五五」規劃綱要是中國發展的新藍圖及世界發展的新機遇。 李強：「中國的進出口是在規則框架下進行的公平貿易，當然我們也高度關注貿易夥伴的關切，願意同各方一起推動貿易優化平衡發展。『十五五』規劃綱要，這不僅是中國發展的新藍圖，也是世界發展的新機遇。」 李強又稱保護主義不是解決問題的靈丹妙藥，應擴大自由貿易，反對無序、非理性的惡性競爭。中方將繼續維護公平競爭的市場秩序，促進全球產供鏈穩定安全，打造良好營商環境，全面落實外資企業國民待遇，讓來華企業安心發展。
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Palantir Technologies (NasdaqGS:PLTR) has had its Maven AI technology designated as a "program of record" by the U.S. Department of Defense. The designation formalizes Maven AI’s adoption across all U.S. military branches and secures stable, long term funding. This move positions...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Palantir Technologies (NasdaqGS:PLTR) has had its Maven AI technology designated as a "program of record" by the U.S. Department of Defense. The designation formalizes Maven AI’s adoption across all U.S. military branches and secures stable, long term funding. This move positions Maven AI as a core component in U.S. military operations, replacing ad hoc or pilot style contracts. Palantir, known for its data analytics and AI software for government and commercial clients, now has Maven AI embedded more formally within U.S. defense planning and budgeting. For readers tracking defense related software providers, this designation stands out because it ties Palantir’s technology directly into the U.S. military’s standard programs rather than short term projects. For investors watching NasdaqGS:PLTR, the new status for Maven AI may influence how they think about the durability of Palantir’s government revenue and the depth of its relationship with the Department of Defense. It also gives context for comparing Palantir’s role against other defense and AI software suppliers that may still be working largely on pilots or one off contracts. Stay updated on the most important news stories for Palantir Technologies by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Palantir Technologies. NasdaqGS:PLTR Earnings & Revenue Growth as at Mar 2026 📰 Beyond the headline: 0 risks and 2 things going right for Palantir Technologies that every investor should see. Quick Assessment ⚖️ Price vs Analyst Target : At US$150.68 versus a US$186.60 consensus target, the price is roughly 19% below where analysts, on average, expect it to be. ❌ Simply Wall St Valuation : Shares are trading about 23.5% above Simply Wall St's estimated fair value, which flags valuation as stretched. ✅ Recent Momentum: A 30 day return of ...
Key Points Kate Mitchell acquired 2,350 RAL shares on Feb. 10, 2026, for a transaction value of ~$100,000 at around $42.48 per share. All shares are held indirectly through The Wesley and Katherine Mitchell Living Trust, with no direct holdings reported after the transaction. After the transaction, Mitchell held 8,411 shares indirectly and 0 shares directly. 10 stocks we like better than Ralliant ...
Key Points Kate Mitchell acquired 2,350 RAL shares on Feb. 10, 2026, for a transaction value of ~$100,000 at around $42.48 per share. All shares are held indirectly through The Wesley and Katherine Mitchell Living Trust, with no direct holdings reported after the transaction. After the transaction, Mitchell held 8,411 shares indirectly and 0 shares directly. 10 stocks we like better than Ralliant › Kate Mitchell, Director of Ralliant (NYSE:RAL), reported an open-market purchase of 2,350 shares for a total consideration of ~$100,000, according to a SEC Form 4 filing dated Feb. 12, 2026. Transaction summary Metric Value Shares traded 2,350 Transaction value $99,828.00 Post-transaction shares (direct) 0 Post-transaction shares (indirect) 8,411 Transaction value based on SEC Form 4 reported price ($42.48). Key questions What was the structure and entity context of this transaction? All 2,350 shares were purchased indirectly through The Wesley and Katherine Mitchell Living Trust, where Mitchell serves as trustee and beneficiary, with no shares acquired or held directly. All 2,350 shares were purchased indirectly through The Wesley and Katherine Mitchell Living Trust, where Mitchell serves as trustee and beneficiary, with no shares acquired or held directly. How did this purchase impact Mitchell's overall ownership stake? The acquisition raised the trust's position by 38.77%, increasing indirect holdings from 6,061 to 8,411 shares, while direct ownership remains at zero. Company overview Metric Value Revenue (TTM) $2.07 billion Net Loss (TTM) $1.22 billion Dividend yield 0.20% Price (as of market close 3/21/26) $40.80 Company snapshot Ralliant provides advanced measurement and sensor technologies for defense and space applications. It designs and manufactures precision instruments, test and measurement systems, and specialty sensors. The company's strategy centers on innovation in precision measurement and sensor technology. What this transaction means for investors Ralli...
Key Points DAFNA Capital Management sold 265,456 AXGN shares in the fourth quarter, with an estimated transaction value of $6.53 million based on quarterly average prices. Meanwhile, the quarter-end position value decreased by $2.36 million, reflecting both trading activity and price movements. After the trade, the fund held 476,826 shares valued at $15.61 million 10 stocks we like better than Axo...
Key Points DAFNA Capital Management sold 265,456 AXGN shares in the fourth quarter, with an estimated transaction value of $6.53 million based on quarterly average prices. Meanwhile, the quarter-end position value decreased by $2.36 million, reflecting both trading activity and price movements. After the trade, the fund held 476,826 shares valued at $15.61 million 10 stocks we like better than Axogen › DAFNA Capital Management cut its holding in Axogen (NASDAQ:AXGN) by 265,456 shares in the fourth quarter, an estimated $6.53 million trade based on quarterly average pricing, according to a February 17, 2026, SEC filing. What happened According to a SEC filing dated February 17, 2026, DAFNA Capital Management reduced its position in Axogen (NASDAQ:AXGN) by 265,456 shares during the fourth quarter of 2025. The estimated transaction value of the sale is $6.53 million, calculated using the average closing price for the quarter. The fund finished the period with 476,826 shares of Axogen, worth $15.61 million at quarter end. What else to know After the sale, Axogen represents 3.63% of the fund's 13F reportable assets under management. Top holdings after the filing include: NASDAQ:RVMD: $48.15 million (11.33% of AUM) NYSEMKT:XBI: $41.03 million (9.65% of AUM) NYSEMKT:STXS: $31.47 million (7.40% of AUM) NASDAQ:ATRC: $23.63 million (5.56% of AUM) NASDAQ:CYTK: $23.57 million (5.55% of AUM) As of Friday, AXGN shares were priced at $30.78, up 71% over the past year and well outperforming the S&P 500, which is instead up about 15% in the same period. Company overview Metric Value Market Capitalization $1.6 billion Revenue (TTM) $225.2 million Net Income (TTM) ($15.7 million) Price (as of Friday) $30.78 Company Snapshot AxoGen develops and markets surgical solutions for peripheral nerve repair, including Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector, AxoGuard Nerve Cap, Avive Soft Tissue Membrane, and AxoTouch two-point discriminator. The firm generates re...
Key Points On March 25, 2026, The Vita Coco Company will join the S&P SmallCap 600, effective prior to the opening of the trading day. The company's stock has been performing strong in previous months, and it recently released a new flavor for one if its popular products. 10 stocks we like better than Vita Coco › Corey Baker, Chief Financial Officer of The Vita Coco Company, Inc. (NASDAQ:COCO), di...
Key Points On March 25, 2026, The Vita Coco Company will join the S&P SmallCap 600, effective prior to the opening of the trading day. The company's stock has been performing strong in previous months, and it recently released a new flavor for one if its popular products. 10 stocks we like better than Vita Coco › Corey Baker, Chief Financial Officer of The Vita Coco Company, Inc. (NASDAQ:COCO), disclosed the sale of 4,000 shares of common stock on March 17, 2026 and March 18, 2026, as detailed in the SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 4,000 Transaction value ~$236,000 Post-transaction shares (direct) 27,951 Post-transaction value (direct ownership) ~$1.56 million Transaction value based on SEC Form 4 weighted average purchase price ($58.98); post-transaction value based on March 18, 2026 market close ($52.88). Key questions What proportion of Baker's holding was impacted by this trade? The sale accounted for 12.52% of Baker's direct common stock holdings prior to the transaction. The sale accounted for 12.52% of Baker's direct common stock holdings prior to the transaction. What is the context of Baker’s transactions? The transactions were executed under a Rule 10b5-1 trading plan, allowing Baker to sell the shares in advance. Company overview Metric Value Revenue (TTM) $609.78 million Net income (TTM) $71.32 million Employees 319 1-year price change 50.44% * 1-year price change calculated as of March 21, 2026. Company snapshot The Vita Coco Company, Inc. develops and distributes coconut-based and functional hydration products, including coconut water, coconut oil, coconut milk, hydration drink mixes, sparkling water, plant-based energy drinks, purified water, and protein-infused fitness drinks. It targets health-conscious consumers in the United States, Canada, Europe, the Middle East, and the Asia Pacific, selling primarily through large retailers, convenience stores, and online platforms. What this transaction means for inves...
"If you are not happy about this government, then in 2027 [you can] just kick it off the bus, change to another government. Now, the matter of the referendum is what counts."
"If you are not happy about this government, then in 2027 [you can] just kick it off the bus, change to another government. Now, the matter of the referendum is what counts."